Lycia Therapeutics Inc. (LYCA)
Snapshot
- 1 week
- -3.8%-3.7% vs SPY
- Market cap
- $1.5B
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Company
Lycia Therapeutics Inc. (LYCA). Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.
- Aetna Wun TrombleyCEO, Secretary, President & DirectorUSD 729K
- Steve StabenChief Scientific OfficerUSD 567K
- Darrin LindhoutVP & Head of Biologics
- Carolyn R. BertozziFounder & Chair of Scientific Advisory Board
- Karen E. FlickGeneral Counsel & Head of Intellectual Property
- Jian CaoVP & Head of CMC
Snapshot
Price & returns1 week -3.8%
- 1 week
- -3.8%-3.7% vs SPY
Valuationmarket cap $1.5B
- Market cap
- $1.5B
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Company
Lycia Therapeutics Inc. (LYCA). Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.
- Aetna Wun TrombleyCEO, Secretary, President & DirectorUSD 729K
- Steve StabenChief Scientific OfficerUSD 567K
- Darrin LindhoutVP & Head of Biologics
- Carolyn R. BertozziFounder & Chair of Scientific Advisory Board
